Orobika Tablet 10/40 mg

Adult dose

This medication is administered once daily, with one tablet taken with water regardless of meals. It is recommended to take it at the same time daily (e.g., morning). The recommended dosages are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with monotherapy of amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: For patients with 20 mg of olmesartan medoxomil.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age.

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to individuals with allergies to the main ingredients or similar medications, to pregnant or breastfeeding women, to patients with severe liver disease, heart valve issues, biliary obstruction, patients on renal dialysis, patients in shock, certain diabetic patients, or patients with severely impaired kidney function. Caution should be exercised in patients with low blood volume or sodium levels, as hypotension may occur, particularly during the initial administration. Patients with significant vascular dilation or heart disease may also need careful monitoring, as rapid vascular expansion can lead to hypotension. In patients with impaired kidney function or liver dysfunction, caution should be exercised as this medication can affect the kidneys or liver. Side effects such as dizziness, headache, hypotension, nausea, swelling, and others may occur during treatment; if unusual symptoms persist, consultation with healthcare professionals is advised. This medication should not be used during pregnancy, and breastfeeding women should either discontinue the medication or stop breastfeeding due to the potential transmission of the drug to the infant. Safety and efficacy have not been established for pediatric patients under 18 years of age. Elderly patients may have impaired liver or kidney function, so dosage adjustments and careful monitoring are necessary. In the case of overdose, hypotension and cardiac arrhythmias may occur, necessitating immediate medical treatment.

Serious side effects

Hives, severe swelling (edema), breathing difficulties, difficulty breathing, angioedema, acute renal failure, hair loss, toxic epidermal necrolysis, liver abnormalities (jaundice and elevated liver enzymes), worsening of cerebral infarction, severe allergic reactions, severe skin reactions, serious neurological symptoms, severe edema or urinary disturbances, severe rashes, blisters, skin peeling, oral/eye mucosal pain, severe allergic reactions, severe rash with high fever, seizures.

Mild side effects

• Dizziness
• headache
• orthostatic hypotension
• drowsiness
• sensory disturbances
• sensory loss
• fainting
• lightheadedness
• palpitations
• tachycardia

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage preserves the medication's efficacy.

Appearance

Reddish-brown round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP X 3)]